凯普生物：董事谢龙旭拟减持不超0.015%公司股份

Core Viewpoint - The company announced a share reduction plan by an employee representative director due to personal financial needs, with a specific timeline and limit on the number of shares to be sold [1] Group 1: Share Reduction Details - The employee representative director, Xie Longxu, holds 375,456 shares, representing 0.0598% of the company's total share capital [1] - The planned reduction will occur within three months from January 7, 2026, to April 6, 2026, with a maximum of 93,864 shares to be sold, which is approximately 0.0150% of the total share capital [1] - The selling price will be determined based on the market price at the time of the reduction [1] Group 2: Uncertainty of Implementation - The implementation of this share reduction plan carries uncertainty [1]